LON:SHP Shire (SHP) Share Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume51,588 shsAverage Volume3.14 million shsMarket Capitalization£42.73 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Shire alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Shire Stock (LON:SHP)Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. Its marketed products include ADVATE, ADYNOVATE/ADYNOVI, and OBIZUR for the treatment of hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand disease; FEIBA to treat hemophilia A and B patients with inhibitors; ELAPRASE to treat hunter syndrome; REPLAGAL for fabry disease; and VPRIV to treat type 1 Gaucher disease. The company's marketed products also comprise VYVANSE/VENVANSE/ELVANSE/TYVENSE/VUXEN/ADUVANZ for the treatment of attention deficit/hyperactivity disorder (ADHD) and binge eating disorder; ADDERALL XR and MYDAYIS to treat ADHD; GAMMAGARD LIQUID/KIOVIG, GAMMAGARD S/D, HYQVIA, and CUVITRU for the treatment of primary immunodeficiency; and FLEXBUMIN to treat hypovolemia and hypoalbuminemia. In addition, its marketed products consists of CINRYZE and FIRAZYR for the treatment of hereditary angioedema; FOSRENOL to treat hyperphosphatemia; LIALDA/MEZAVANT and PENTASA for ulcerative colitis; GATTEX/REVESTIVE for the treatment of short bowel syndrome; NATPARA for the control of hypocalcemia in patients with hypoparathyroidism; ONCASPAR to treat acute lymphoblastic leukemia; ONYVIDE for metastatic adenocarcinoma of the pancreas; and XIIDRA for the treatment of dry eye disease. The company markets its products through wholesalers, distributors, and pharmacies. It has collaborative and other licensing arrangements with Rani Therapeutics LLC; Parion Sciences Inc.; Pfizer Inc.; Precision BioSciences Inc.; Symphogen; and Ipsen Bioscience Inc., as well as a preclinical research collaboration agreement with NanoMedSyn. The company was founded in 1986 and is headquartered in Dublin, Ireland.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. SHP Stock News HeadlinesApril 5, 2024 | morningstar.comSouth Harz Potash Ltd SHPOctober 20, 2022 | bbc.comWhy the capture of Shire is so important for Ethiopia - BBCJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.October 17, 2022 | reuters.comEthiopian army captures large city from Tigray forces: sources - ReutersOctober 16, 2022 | barrons.comAU Calls On Ethiopia Rivals To 'Recommit' To Peace - Barron'sOctober 12, 2022 | news.yahoo.comShire Chic? This $30 Million Mountaintop Lodge in North Carolina Comes With a Hobbit-Style Guest House - Yahoo NewsOctober 11, 2022 | nypost.comLoose lips lead to lawsuits over allegations from 'The Godfather' set - New York Post October 11, 2022 | yahoo.comShire Chic? This $30 Million Mountaintop Lodge in North Carolina Comes With a Hobbit-Style Guest House - Yahoo LifeJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.October 9, 2022 | uk.news.yahoo.comDeputy Mayor and Thwaites Horse Shire team open new kitchen facility - Yahoo News UKOctober 7, 2022 | forbes.comKansas City Chiefs Linemen Creed Humphrey And Trey Smith Use T-Shirts To Build Brand - ForbesOctober 7, 2022 | cnn.comKanye West tells Tucker Carlson he thought 'White Lives Matter' shirt was 'funny' - CNNOctober 1, 2022 | mirror.co.ukThe Queen's 'special' grey shire horses pay their respects with final act of service - The MirrorSeptember 30, 2022 | dailymail.co.ukJANE FRYER: Queen's 'special' grey shire horses 'pay their respects' to the late monarch - Daily MailSeptember 30, 2022 | startribune.comWitnesses: Airstrike in Ethiopia's Tigray kills civilians - Star TribuneSeptember 30, 2022 | abcnews.go.comWitnesses: Airstrike in Ethiopia's Tigray kills civilians - ABC NewsSeptember 27, 2022 | forbes.com2023 Bentley Bentayga EWB First Drive: A Thoroughbred Among Shire Horses - ForbesSeptember 26, 2022 | uk.news.yahoo.comTwo Shire horses take Queen’s flowers away for composting - Yahoo News UKSee More Headlines Receive SHP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shire and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SHP CUSIPN/A CIKN/A Webwww.shire.com Phone+353-1-6096000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares910,982,976Free FloatN/AMarket Cap£42.73 billion OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Flemming Ornskov M.P.H. (Age 60)MBA, M.D., MPH, CEO, MD & Exec. Director Mr. Thomas J. W. Dittrich (Age 54)CFO & Director Gisele DionChief Accounting OfficerMr. Matthew Walker (Age 54)Head of Technical Operations Dr. Andreas Busch Ph.D. (Age 55)Head of R&D and Chief Scientific Officer Key CompetitorsBTGLON:BTGAbcamLON:ABCGenusLON:GNSOxford Nanopore TechnologiesLON:ONTErgomedLON:ERGOView All Competitors Should I Buy Shire Stock? SHP Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Shire plc: Shire plc is a biotechnology company that researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. Recent developments in the company's therapeutic areas, including hematology, genetic diseases, and neuroscience, show promising advancements in treatment options. Shire plc has a strong track record of innovation and bringing new products to market, which can lead to potential revenue growth. The company's focus on rare diseases and specialized conditions provides a niche market opportunity with potentially less competition. Current stock price of Shire plc is stable and has shown positive growth trends in recent periods, indicating a potential for good returns on investment. Cons Investors should be bearish about investing in Shire plc for these reasons: Shire plc operates in the highly regulated biotechnology and pharmaceutical industry, which can pose challenges in terms of compliance and market approvals. Market volatility and changes in healthcare policies can impact the company's revenue streams and profitability. Competition from other biotech companies and potential disruptions in supply chains could affect Shire plc's market position. Investing in biotechnology companies carries inherent risks related to clinical trial outcomes, regulatory approvals, and patent protections. While the company has shown growth potential, investors should carefully consider the risks associated with investing in a specialized sector like rare diseases and biotechnology. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 5, 2024. Please send any questions or comments about these Shire pros and cons to contact@marketbeat.com. SHP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Shire own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shire investors own include Barclays (BARC), Centrica (CNA), Erie Indemnity (ERIE), Lloyds Banking Group (LLOY), GSK (GSK), International Consolidated Airlines Group (IAG) and Vodafone Group Public (VOD). This page (LON:SHP) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shire plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
